Abstract
Importance Down syndrome, resulting from trisomy 21, is the most prevalent chromosomal disorder and a leading cause of intellectual disability. Despite its significant impact on brain development, research on the white matter microstructure in infants with Down syndrome remains limited.
Objective To investigate early white matter microstructure in infants with Down syndrome using diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI).
Design Infants were recruited and scanned between March 2019 and May 2024 as participants in prospective studies conducted by the Infant Brain Imaging Study (IBIS) Network. Data were analyzed in October 2024.
Setting Data collection occurred at five research centers in Minnesota, Missouri, North Carolina, Pennsylvania, and Washington.
Participants Down syndrome and control infants were scanned at 6 months of age. Control infants had no Down syndrome diagnosis and either had a typically developing older sibling or, if they had an older sibling with autism, were confirmed not to meet clinical best estimate criteria for an autism diagnosis.
Exposure Diagnosis of Down syndrome.
Main Outcomes and Measures The outcome of interest was white matter microstructure quantified using DTI and NODDI measures.
Results A total of 49 Down syndrome (28 [57.14%] female) and 37 control (18 [48.65%] female) infants were included. Infants with Down syndrome showed significant reductions in fractional anisotropy and neurite density index across multiple association tracts, particularly in the inferior fronto-occipital fasciculus and superior longitudinal fasciculus II, consistent with reduced structural integrity and neurite density. These tracts also demonstrated increased radial diffusivity, suggesting delayed myelination. The inferior fronto-occipital fasciculus and uncinate fasciculus exhibited increased neurite dispersion and fanning in Down syndrome infants, reflected by elevated orientation dispersion index. Notably, the optic tracts in Down syndrome infants exhibited a distinct pattern of elevated fractional anisotropy and axial diffusivity, and lower radial diffusivity and orientation dispersion index, suggesting an early maturation of these pathways.
Conclusions and Relevance This first characterization of white matter microstructure in Down syndrome infants reveals widespread white matter developmental delays. These findings provide new insights into the early neurodevelopment of Down syndrome and may inform early therapeutic interventions.
Competing Interest Statement
Dr. Robert McKinstry holds stock options in Turing Medical and serves as a paid member of its medical advisory board. He also receives travel, lodging, and meal support from Siemens Healthcare and Radiaction, as well as meal support from Hyperfine.
Funding Statement
This study was supported by grants from the National Institutes of Health (R01HD088125, K01HD109445, K23HD112809, R01HD055741, R01MH118362, R01MH118362–02S1, P50HD103573–8084, T32HD040127, K01MH122779).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRBs of the Childrens Hospital of Philadelphia, The University of Minnesota, The University of North Carolina at Chapel Hill, The University of Washington relying on a parent IRB at Washington University in St. Louis all gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* shared senior authorship
The author list has been updated to include an essential contributor, and the license has been changed to CC-BY. No other changes have been made to the manuscript or its supplemental files.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
